US Patent 7741445 Breast cancer resistance protein (BCRP) antibodies
Patent 7741445 was granted and assigned to University of Maryland, Baltimore on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+191 characters)
Article
Patent abstract
The Breast Cancer Resistance Protein is described, as well as the cDNA encoding said protein. This protein has been found to confer resistance to cancer chemotherapeutic drugs.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Douglas D Ross0
L. Austin Doyle0
Lynne V. Abruzzo0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07741445 Breast cancer resistance protein (BCRP) antibodies US Patent 7741445 Breast cancer resistance protein (BCRP) antibodies
Infobox
Patent Number
07741445
Patent Number
7741445
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07741445 Breast cancer resistance protein (BCRP) antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07741445
Date of patent
June 22, 2010
Patent application number
12060738
Date Filed
April 1, 2008
Patent primary examiner
Find more entities like US Patent 7741445 Breast cancer resistance protein (BCRP) antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
